Houston, TX, United States of America

Nghi D Nguyen

This inventor holds 2 USPTO granted patents. Top assignee: Lexicon Genetics Corporation. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nghi D Nguyen. Retrieved from https://idiyas.com/inventor/nghi-d-nguyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nghi D Nguyen: Innovator in Human Kielin-like Proteins

Introduction

Nghi D Nguyen is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the area of human polynucleotide and polypeptide sequences. With a total of 2 patents, his work has implications for therapeutic, diagnostic, and pharmacogenomic applications.

Latest Patents

Nguyen's latest patents include innovative discoveries related to human kielin-like proteins and the polynucleotides encoding them. These novel sequences are disclosed for their potential use in various medical applications, showcasing Nguyen's commitment to advancing healthcare through scientific research.

Career Highlights

Nghi D Nguyen is currently associated with Lexicon Genetics Corporation, where he continues to push the boundaries of genetic research. His work at the company has positioned him as a key player in the development of new therapeutic strategies.

Collaborations

Nguyen has collaborated with notable colleagues, including Xuanchuan Yu and John Scoville, to further enhance the impact of his research. Their combined expertise contributes to the innovative environment at Lexicon Genetics Corporation.

Conclusion

Nghi D Nguyen's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…